Show simple item record

dc.contributor.authorHamishehkar, H
dc.contributor.authorEbrahimi, D
dc.contributor.authorMahmoodpoor, A
dc.contributor.authorMashayekhi, S
dc.contributor.authorAsgharian, P
dc.contributor.authorReazee, H
dc.date.accessioned2018-08-26T08:52:01Z
dc.date.available2018-08-26T08:52:01Z
dc.date.issued2015
dc.identifier10.15171/PS.2015.13
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53602
dc.description.abstractBackground: Drug Utilization Evaluation (DUE) studies are designed to evaluate drug usage appropriateness. In this study we evaluated the relevant use of vancomycin in a teaching hospital in Iran. The results of this study may be of help for clinicians to improve the patient care. Methods: The use of vancomycin was evaluated in a cross-sectional and prospective study from October 2011 until June 2012. Vancomycin administration was assessed according to CDC and ASHP guidelines. Predesigned data collection was implemented in this study. Information collected from medical records, patient's history, medical orders, nursing reports and the experimental results available in the patient's records. Results: During the study period, 75 cases were been evaluated from all of the hospital wards. The median age of patients was 46.65آ±20.04 years (mean آ± SD). The median time of vancomycin use in the study population was 9.35آ±5.70 days. most of the patients received vancomycin, had been hospitalized for trauma problems. In this study 30.7% of cases received vancomycin appropriately and in accordance to standard guidelines. Conclusion: Based on the results of our study, a substantial percentage of the patients (69.3%), received vancomycin inappropriately. It is essential to promote practical guidelines about utilizing culture and sensitivity testing when considering the use of important and broad spectrum antibiotics. Also educational programs for health care professionals regarding rational use of antibiotics can be helpful in improving antimicrobial medications utilization and monitoring. é 2015 The Authors.
dc.language.isoEnglish
dc.relation.ispartofPharmaceutical Sciences
dc.subjectaminoglycoside antibiotic agent
dc.subjectvancomycin
dc.subjectadult
dc.subjectantibiotic prophylaxis
dc.subjectantibiotic therapy
dc.subjectArticle
dc.subjectbacterial arthritis
dc.subjectcellulitis
dc.subjectcentral nervous system disease
dc.subjectcross-sectional study
dc.subjectdrug monitoring
dc.subjectdrug use
dc.subjectdrug utilization
dc.subjectdrug withdrawal
dc.subjectevaluation study
dc.subjectfasciitis
dc.subjectfemale
dc.subjectGram positive infection
dc.subjecthospital patient
dc.subjecthuman
dc.subjectinjury
dc.subjectIran
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmedical history
dc.subjectmedical order
dc.subjectmedical record review
dc.subjectmeningitis
dc.subjectmiddle aged
dc.subjectosteoarthritis
dc.subjectosteomyelitis
dc.subjectpatient care
dc.subjectpneumonia
dc.subjectpostoperative infection
dc.subjectpractice guideline
dc.subjectprospective study
dc.subjectpseudomembranous colitis
dc.subjectsepsis
dc.subjectStaphylococcus infection
dc.subjectteaching hospital
dc.subjectvertebral canal stenosis
dc.subjectward
dc.titleDrug utilization evaluation of vancomycin in a teaching hospital in Tabriz-Iran
dc.typeArticle
dc.citation.volume21
dc.citation.issue1
dc.citation.spage25
dc.citation.epage29
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.15171/PS.2015.13


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record